Clinical Trials, Registries and Research

If you meet the patient criteria set for a particular trial, and you decide to participate, you may experience any or all of these benefits:

• Patients who participate in clinical trials often fare better than those who do not because they are followed better and monitored more closely
• Many studies are done on patients living with cancer and these studies offer them a chance for a cure or at least prolonged life that they may not otherwise experience
• Often the new techniques are less invasive, which means quicker recovery time, less scarring and shorter hospital stays
• As well, you will have the opportunity to improve breast cancer care for future patients.

Current Clinical Trials

Tissue studies: In an effort to study breast cancer and to figure out how we can best treat it, a number of studies rely on looking at breast cancer tissue and normal tissue. You can help by participating in studies in which some of your tumor is used for research. This tissue would otherwise be waste, and therefore would not affect your diagnosis or treatment.

NCIC - MA.27: A Randomized Phase III Trial of Exemestane versus Anastrozole in Postmenopausal Women with Receptor Positive Primary Breast Cancer.

NCIC – MA.27-B: A clinical trial to examine whether there is a clinically relevant difference in impact on bone mineral density between the steroidal (exemestane) and the non-steroidal (anastrozole) therapy received in the MA.27 study.

NCIC – MA.27-D: A clinical trial to look at changes in breast density before and after the therapy received in the MA-27 study.

Detection of Malignancy in Nipple Aspirate Fluid: A clinical trial to test the ability of a new laboratory method to detect breast cancer in nipple fluid.

Decision Analysis in Breast Cancer: A questionnaire study designed to evaluate how to best convey treatment options and what motivates patients to choose one treatment option versus another.

For more information regarding clinical trials, please call 502-629-6950.